PREVENTION OF CORONARY-THROMBOSIS WITH SUBTHROMBOLYTIC DOSES OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR

被引：77

作者：

FOX, KAA

ROBISON, AK

KNABB, RM

ROSAMOND, TL

SOBEL, BE

BERGMANN, SR

机构：

来源：

CIRCULATION | 1985年 / 72卷 / 06期

关键词：

D O I：

10.1161/01.CIR.72.6.1346

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1346 / 1354

页数：9

共 34 条

[1] TEMPORAL DEPENDENCE OF BENEFICIAL-EFFECTS OF CORONARY THROMBOLYSIS CHARACTERIZED BY POSITRON TOMOGRAPHY [J].

BERGMANN, SR ;

LERCH, RA ;

FOX, KAA ;

LUDBROOK, PA ;

WELCH, MJ ;

TERPOGOSSIAN, MM ;

SOBEL, BE .

AMERICAN JOURNAL OF MEDICINE, 1982, 73 (04) :573-581

[2]

BERGMANN SR, 1983, SCIENCE, V220, P1181

[3] THE LEVEL OF EXTRINSIC PLASMINOGEN-ACTIVATOR (T-PA) DURING CLOTTING AS A DETERMINANT OF THE RATE OF FIBRINOLYSIS - INEFFICIENCY OF ACTIVATORS ADDED AFTERWARDS [J].

BROMMER, EJP .

THROMBOSIS RESEARCH, 1984, 34 (02) :109-115

[4]

Castellino F J, 1976, Methods Enzymol, V45, P244

[5]

CLAUSS A., 1957, ACTA HAEMATOL, V17, P237

[6] CORONARY THROMBOLYSIS WITH RECOMBINANT HUMAN TISSUE-TYPE PLASMINOGEN-ACTIVATOR - A PROSPECTIVE, RANDOMIZED, PLACEBO-CONTROLLED TRIAL [J].

COLLEN, D ;

TOPOL, EJ ;

TIEFENBRUNN, AJ ;

GOLD, HK ;

WEISFELDT, ML ;

SOBEL, BE ;

LEINBACH, RC ;

BRINKER, JA ;

LUDBROOK, PA ;

YASUDA, I ;

BULKLEY, BH ;

ROBISON, AK ;

HUTTER, AM ;

BELL, WR ;

SPADARO, JJ ;

KHAW, BA ;

GROSSBARD, EB .

CIRCULATION, 1984, 70 (06) :1012-1017

[7]

COLLEN D, 1980, THROMB HAEMOSTASIS, V43, P77

[8] CORONARY THROMBOLYSIS - PHARMACOLOGICAL CONSIDERATIONS WITH EMPHASIS ON TISSUE-TYPE PLASMINOGEN-ACTIVATOR (T-PA) [J].

FOX, KAA ;

BERGMANN, SR ;

SOBEL, BE .

BIOCHEMICAL PHARMACOLOGY, 1984, 33 (12) :1831-1838

[9] SUBUNIT STRUCTURE OF PLASMIN-INDUCED DEGRADATION PRODUCTS OF CROSSLINKED FIBRIN [J].

GAFFNEY, PJ ;

BRASHER, M .

BIOCHIMICA ET BIOPHYSICA ACTA, 1973, 295 (01) :308-313

[10]

GASH AK, 1984, CIRCULATION, V70, P256

← 1 2 3 4 →